Group structure
2 companies in 2 countries
Iceland1
United States1
Groups are put together by Prognia from the names regulators publish and from company links; they are not an official corporate structure.
Medicines
Every medicine of every company in the group, current ones first.
10 medicines
| Medicine | Substance | Country | Status | Authorised |
|---|---|---|---|---|
| Selarsdi130mg/26ml (5mg/ml) ยท Injection | Ustekinumab | United States | Marketed | 2024 |
| SELARSDI45mg/0.5ml | 90mg/ml ยท Injectable | Ustekinumab | United States | Marketed | 2024 |
| Selarsdi45mg/0.5ml ยท Injection | Ustekinumab | United States | Marketed | 2025 |
| Simlandi40mg/0.4ml ยท Injection | Adalimumab | United States | Marketed | 2024 |
| Simlandi80mg/0.8ml ยท Injection | Adalimumab | United States | Marketed | 2024 |
| SIMLANDI40mg/0.4ml ยท Injectable | Adalimumab | United States | Marketed | 2024 |
| Simlandi80mg/0.8ml ยท Injection | Adalimumab | United States | Marketed | 2025 |
| Simlandi20mg/0.2ml ยท Injection | Adalimumab | United States | Marketed | 2024 |
| SIMLANDI 40MG/0.4ML SOLUTION FOR INJECTION PFS | Adalimumab | Saudi Arabia | Authorised | |
| SIMLANDI 80MG/0.4ML SOLUTION FOR INJECTION PFS | Adalimumab | Saudi Arabia | Authorised |



